CN1813783A - 一种阿奇霉素微丸胶囊及其制备方法 - Google Patents
一种阿奇霉素微丸胶囊及其制备方法 Download PDFInfo
- Publication number
- CN1813783A CN1813783A CN 200510061860 CN200510061860A CN1813783A CN 1813783 A CN1813783 A CN 1813783A CN 200510061860 CN200510061860 CN 200510061860 CN 200510061860 A CN200510061860 A CN 200510061860A CN 1813783 A CN1813783 A CN 1813783A
- Authority
- CN
- China
- Prior art keywords
- micropill
- azithromycin
- capsule
- preparation
- micro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title claims abstract description 66
- 229960004099 azithromycin Drugs 0.000 title claims abstract description 66
- 239000002775 capsule Substances 0.000 title claims abstract description 48
- 239000006187 pill Substances 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 28
- 239000008188 pellet Substances 0.000 claims description 34
- 239000012530 fluid Substances 0.000 claims description 20
- 239000011230 binding agent Substances 0.000 claims description 19
- 239000000725 suspension Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 11
- 230000001476 alcoholic effect Effects 0.000 claims description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 7
- 230000002572 peristaltic effect Effects 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- -1 hydroxypropyl Chemical group 0.000 claims description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 abstract 2
- 230000001070 adhesive effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 description 25
- 238000012856 packing Methods 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 239000007921 spray Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000004090 dissolution Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 238000005286 illumination Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 206010013786 Dry skin Diseases 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 235000010603 pastilles Nutrition 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241001647372 Chlamydia pneumoniae Species 0.000 description 2
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000002741 palatine tonsil Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000606766 Haemophilus parainfluenzae Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940003827 azithromycin 500 mg Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- QZIQJVCYUQZDIR-UHFFFAOYSA-N mechlorethamine hydrochloride Chemical compound Cl.ClCCN(C)CCCl QZIQJVCYUQZDIR-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
性状 | 含量% | 有关物质% | 溶出度% | ||
第0天 | 类白色微丸 | 99.81 | 符合规定 | 99.77 | |
光照 | 裸露 | 类白色微丸 | 99.71 | 符合规定 | 94.68 |
包装 | 类白色微丸 | 99.23 | 符合规定 | 95.26 | |
高温 | 裸露 | 类白色微丸 | 99.61 | 符合规定 | 96.06 |
包装 | 类白色微丸 | 99.22 | 符合规定 | 95.49 | |
高湿 | 裸露 | 类白色微丸 | 99.08 | 符合规定 | 94.44 |
包装 | 类白色微丸 | 98.56 | 符合规定 | 95.68 |
性状 | 含量% | 有关物质% | 溶出度% | ||
第0天 | 类白色微丸 | 99.75 | 符合规定 | 99.69 | |
光照 | 裸露 | 类白色微丸 | 99.45 | 符合规定 | 94.50 |
包装 | 类白色微丸 | 99.33 | 符合规定 | 95.21 | |
高温 | 裸露 | 类白色微丸 | 99.51 | 符合规定 | 95.63 |
包装 | 类白色微丸 | 99.34 | 符合规定 | 94.71 | |
高湿 | 裸露 | 类白色微丸 | 99.32 | 符合规定 | 95.12 |
包装 | 类白色微丸 | 98.45 | 符合规定 | 95.33 |
性状 | 含量% | 有关物质% | 溶出度% | ||
第0天 | 类白色微丸 | 99.79 | 符合规定 | 99.58 | |
光照 | 裸露 | 类白色微丸 | 99.53 | 符合规定 | 95.23 |
包装 | 类白色微丸 | 99.42 | 符合规定 | 95.51 | |
高温 | 裸露 | 类白色微丸 | 99.44 | 符合规定 | 95.88 |
包装 | 类白色微丸 | 99.53 | 符合规定 | 95.61 | |
高湿 | 裸露 | 类白色微丸 | 99.60 | 符合规定 | 95.01 |
包装 | 类白色微丸 | 98.25 | 符合规定 | 95.54 |
性状 | 含量% | 有关物质% | 溶出度% | ||
第0天 | 类白色微丸 | 99.85 | 符合规定 | 99.66 | |
光照 | 裸露 | 类白色微丸 | 99.75 | 符合规定 | 94.53 |
包装 | 类白色微丸 | 99.31 | 符合规定 | 95.52 | |
高温 | 裸露 | 类白色微丸 | 99.51 | 符合规定 | 96.17 |
包装 | 类白色微丸 | 99.12 | 符合规定 | 95.39 |
高湿 | 裸露 | 类白色微丸 | 99.17 | 符合规定 | 94.54 |
包装 | 类白色微丸 | 98.61 | 符合规定 | 95.47 |
时间min | 溶出度测定结果(%) | |||
实施例1 | 实施例2 | 实施例3 | 实施例4 | |
5 | 50.08 | 51.56 | 51.98 | 51.40 |
8 | 93.91 | 92.87 | 93.50 | 93.09 |
10 | 95.97 | 95.49 | 95.83 | 95.87 |
12 | 100.51 | 99.87 | 102.20 | 100.63 |
15 | 99.71 | 100.91 | 102.86 | 99.84 |
30 | 99.16 | 99.87 | 100.71 | 101.24 |
45 | 98.57 | 98.72 | 100.82 | 98.36 |
50 | 98.48 | 98.51 | 100.14 | 98.98 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100618607A CN100500161C (zh) | 2005-12-07 | 2005-12-07 | 一种阿奇霉素微丸胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100618607A CN100500161C (zh) | 2005-12-07 | 2005-12-07 | 一种阿奇霉素微丸胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1813783A true CN1813783A (zh) | 2006-08-09 |
CN100500161C CN100500161C (zh) | 2009-06-17 |
Family
ID=36906215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100618607A Active CN100500161C (zh) | 2005-12-07 | 2005-12-07 | 一种阿奇霉素微丸胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100500161C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813633A (zh) * | 2011-06-10 | 2012-12-12 | 塔科敏斯基制药厂波尔法合资公司 | 用湿法制粒制备包含大环内酯类抗生素的药物组合物的方法 |
CN107582538A (zh) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | 阿奇霉素胶囊及其制备方法 |
CN112656774A (zh) * | 2020-12-26 | 2021-04-16 | 海南葫芦娃药业集团股份有限公司 | 一种阿奇霉素肠溶胶囊及其制备方法 |
-
2005
- 2005-12-07 CN CNB2005100618607A patent/CN100500161C/zh active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813633A (zh) * | 2011-06-10 | 2012-12-12 | 塔科敏斯基制药厂波尔法合资公司 | 用湿法制粒制备包含大环内酯类抗生素的药物组合物的方法 |
CN107582538A (zh) * | 2017-06-01 | 2018-01-16 | 合肥远志医药科技开发有限公司 | 阿奇霉素胶囊及其制备方法 |
CN112656774A (zh) * | 2020-12-26 | 2021-04-16 | 海南葫芦娃药业集团股份有限公司 | 一种阿奇霉素肠溶胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100500161C (zh) | 2009-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104546907B (zh) | 一种肠溶纳米氧化锌制剂及其制备方法 | |
CN1931137A (zh) | 盐酸小檗碱掩味微丸及其制剂 | |
CN1237976C (zh) | 必特螺旋霉素及其在抗感染性疾病中的应用 | |
CN102600132B (zh) | 一种含氨磺必利的口服制剂 | |
CN104814931B (zh) | 一种喹乙醇缓释颗粒及其制备方法和应用 | |
CN1813783A (zh) | 一种阿奇霉素微丸胶囊及其制备方法 | |
CN101590021A (zh) | 头孢呋辛酯掩味微丸及制备方法 | |
CN1823804A (zh) | 一种克拉霉素速释微丸及其制备方法 | |
CN1813758A (zh) | 一种盐酸左氧氟沙星微丸胶囊及其制备方法 | |
CN104666250B (zh) | 一种金霉素缓释微球的制备方法 | |
CN112494460B (zh) | 替米考星粉剂及其制备方法 | |
CN110384802A (zh) | 一种用于预防和/或治疗发热的药物、组合产品及其应用 | |
CN1319533C (zh) | 盐酸头孢他美酯分散片及其制备方法 | |
CN1284540C (zh) | 阿奇霉素肠溶制剂及其制备方法 | |
CN103948621A (zh) | 一种香菇多糖的口服剂型及其制备方法 | |
CN1296050C (zh) | 阿卡波糖肠溶片及制备方法 | |
CN100337625C (zh) | 阿那曲唑的分散片剂型 | |
CN1589807A (zh) | 一种红霉素微丸型肠溶片及其制备方法 | |
CN1903869A (zh) | 替比夫定的衍生物盐及其制备方法和药物应用 | |
CN1201736C (zh) | 甲硝唑结肠定位缓释制剂 | |
CN1268342C (zh) | 药物组合物 | |
CN111569045A (zh) | 一种氟苯尼考可溶性粉粉剂药物 | |
CN105997894B (zh) | 一种兽用金霉素预混剂及其制备方法 | |
CN1931175A (zh) | 一种防治畜禽呼吸道和消化道疾病的药物组合物 | |
CN1241572C (zh) | 阿司匹林缓控释胶囊制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HAINAN POLY PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: FAN MINHUA Effective date: 20100707 Owner name: ZHEJIANG RUIDA PHARMACEUTICAL CO., LTD. HANGZHOU S |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310009 NO.10, LINMU LANE, SHANGCHENG DISTRICT, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 571127 GUILINYANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, MEILAN DISTRICT, HAIKOU CITY, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100707 Address after: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Co-patentee after: Zhejiang Ruida Pharmaceutical Co.,Ltd. Patentee after: Hainan Poly Pharm Co.,Ltd. Co-patentee after: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. Address before: 310009, Lane 10, Shangcheng District, Zhejiang, Hangzhou Patentee before: Fan Minhua |
|
CI01 | Publication of corrected invention patent application |
Correction item: Patentee Correct: Zhejiang Ruida Pharm Co.,Ltd. False: Zhejiang Ruida Pharmaceutical Co.,Ltd. Number: 33 Volume: 26 |
|
CI03 | Correction of invention patent |
Correction item: Patentee Correct: Zhejiang Ruida Pharm Co.,Ltd. False: Zhejiang Ruida Pharmaceutical Co.,Ltd. Number: 33 Page: The title page Volume: 26 |
|
C56 | Change in the name or address of the patentee |
Owner name: HAINAN PLOY PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: HAINAN PULIN PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Patentee after: HAINAN POLY PHARM. Co.,Ltd. Patentee after: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Patentee after: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. Address before: 571127 Guilin economic and Technological Development Zone, Meilan District, Hainan, Haikou Patentee before: Hainan Poly Pharm Co.,Ltd. Patentee before: Zhejiang Ruida Pharm Co.,Ltd. Patentee before: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Zhu Xulei Document name: Deemed not to have given notice |
|
DD01 | Delivery of document by public notice | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230117 Address after: 571127 Guilin Ocean Economic Development Zone, Meilan District, Haikou City, Hainan Province Patentee after: HAINAN POLY PHARM. Co.,Ltd. Patentee after: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Address before: 571127 Guilin Ocean Economic and Technological Development Zone, Meilan District, Haikou City, Hainan Province Patentee before: HAINAN POLY PHARM. Co.,Ltd. Patentee before: ZHEJIANG POLY PHARMACEUTICAL Co.,Ltd. Patentee before: HANGZHOU SHARPLY PHARM R&D INSTIT. Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Zhu Xulei Document name: Notification of Conformity |